Back
Immunovant Stock Predictions

#1 Low-Priced Lithium Stock as Global EV Sales Accelerate
Find out more here.
Buy
88
IMVT
Immunovant
Last Price:
39.14
Seasonality Move:
-5.87%
7 Day Trial
ALL ACCESS PASS
$
7

Tiny Lithium Stock Gets $90M Boost in Global EV Battery Race
Learn more here.Immunovant Stock Forecast
- Over the next 52 weeks, Immunovant has on average historically risen by 126.3% based on the past 4 years of stock performance.
- Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Immunovant Stock Undervalued?
The current Immunovant [IMVT] share price is $39.11. The Score for IMVT is 88, which is 76% above its historic median score of 50, and infers lower risk than normal. - IMVT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
Will Immunovant Stock Go Up Next Year?
- Over the next 52 weeks, Immunovant has on average historically risen by 126.3% based on the past 4 years of stock performance.
Immunovant Stock Rating
Buy
88
Immunovant (IMVT)
is a Buy
Is Immunovant overpriced?
- Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Immunovant Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
immunovant.com
52-Week Data
52-Week High:
44.19
52-Week Low:
12.77
Prediction Charts
Market Cap:
5.66B
Price in USD:
39.11
Volume:
2.62M
Beta:
0.72
Technical Analysis
SMA50:
34.28
SMA100:
28.04
SMA200:
23.02
52-Wk Change:
198.32%
Stock Predictions
-
Is Immunovant stock public?
Yes, Immunovant is a publicly traded company. -
What is the Immunovant stock quote today?
The Immunovant stock price is 39.11 USD today. -
How to buy Immunovant stock online?
You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-10 | 31.84 | 32.63 | 32.82 | 31.52 |
Nov-13 | 32.37 | 32.80 | 33.35 | 31.60 |
Nov-14 | 34.24 | 34.97 | 35.00 | 33.83 |
Nov-15 | 34.97 | 34.25 | 35.91 | 34.24 |
Nov-16 | 33.80 | 33.72 | 34.44 | 33.44 |
Nov-17 | 34.05 | 33.79 | 34.40 | 33.62 |
Nov-20 | 34.28 | 33.80 | 35.09 | 33.66 |
Nov-21 | 33.27 | 32.96 | 33.90 | 32.95 |
Nov-22 | 33.30 | 32.68 | 34.08 | 32.36 |
Nov-24 | 32.63 | 33.42 | 34.15 | 32.49 |
Nov-27 | 33.42 | 33.54 | 33.70 | 31.84 |
Nov-28 | 34.52 | 36.01 | 36.81 | 32.34 |
Nov-29 | 36.18 | 38.24 | 40.00 | 36.16 |
Nov-30 | 38.81 | 39.11 | 40.90 | 38.47 |
Immunovant Earnings
Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.
Immunovant Forecast Revenue Growth
Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.22 per share.
* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.